Founder Lodge | Aviceda Therapeutics raises $207,500,000 at …

Founder Lodge | Aviceda Therapeutics Raises $207,500,000 At …

3 weeks from now

Jan 8, 2025  · Aviceda Therapeutics raises $207,500,000 at Series C on 2025-01-08 in Biotechnology Research, industry founded/co-founded by Michael Tolentino

founderlodge.com

Aviceda Therapeutics Raises Upsized $207.5 Million In Series C ...

3 weeks from now

Jan 7, 2025  · Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round to Advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials. ... Founder and …

businesswire.com

Aviceda Therapeutics - Founder Lodge

3 weeks from now

Jan 8, 2025  · Certified by Founder Lodge . Aviceda Therapeutics ... Cambridge, Massachusetts . START UP . 1 Disclosed Funding Rounds $207,500,000 0 Participating Investments. …

founderlodge.com

Aviceda Therapeutics Raises Upsized $207.5 Million In Series C ...

3 weeks from now

CAMBRIDGE, Mass., January 07, 2025--Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round. ... Chen Yu, M.D., M.B.A., Founder and Managing Partner at …

yahoo.com

Aviceda Raises $207M For Geographic Atrophy Drug's Ph. 3 Journey

3 weeks from now

Jan 7, 2025  · Aviceda Therapeutics has secured $207.5 million in series C funds as the immunomodulator-focused biotech awaits a phase 3 readout this year for its lead eye disease …

fiercebiotech.com

Aviceda Therapeutics Raises Upsized $207.5 Million In Series C ...

3 weeks from now

Jan 7, 2025  · About Aviceda Therapeutics and AVD-104 Aviceda is a private, clinical-stage biotechnology company located in Cambridge, MA, with a proprietary High Affinity Ligands of …

biospace.com

Aviceda Raises $207.5m For Eye Drug, And Other Financings

3 weeks from now

Jan 30, 2025  · Aviceda Therapeutics has got biotech financing in 2025 off to a flying start by raising $207.5 million to take its lead drug for sight-robbing disease geographic atrophy (GA) …

pharmaphorum.com

Aviceda Therapeutics Raises Upsized $207.5M In Series C Financing

3 weeks from now

Jan 8, 2025  · Aviceda Therapeutics, a Cambridge, MA-based private, clinical-stage biotech company focused on developing new immunomodulators, raised $207.5M in Series C …

finsmes.com

Aviceda Therapeutics: $207.5 Million (Series C) Raised To Develop …

3 weeks from now

Jan 8, 2025  · Aviceda Therapeutics, a private, clinical-stage biotech company focused on developing next-generation immunomodulators with a proprietary High Affinity Ligands of …

pulse2.com

Aviceda Raises $207.5 Million In Series C Funding To Advance

3 weeks from now

Jan 7, 2025  · Aviceda Therapeutics secured $207.5 million in Series C financing to advance the AVD-104 program in geographic atrophy, according to a press release. Omega Funds and …

healio.com

Jeito Capital Announces Significant Participation In Upsized $207.5 ...

3 weeks from now

Jan 7, 2025  · Jeito Capital announces significant participation in upsized $207.5 million Series C financing in Aviceda Therapeutics to advance Lead Program AVD-104 for Geographic Atrophy …

yahoo.com

Aviceda Therapeutics Raises Upsized $207.5 Million In Series C ...

3 weeks from now

Jan 7, 2025  · Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round to Advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials. By: Aviceda …

financialcontent.com

Aviceda Therapeutics 1/8/2025 Capital Raise - Gaebler.com

3 weeks from now

Jan 8, 2025  · Raise Money; Entrepreneurial Finance; Business Tax Tips; Accounting; Selling a Business; ... Aviceda Therapeutics, based in Cambridge, secured $207.5 million in investment …

gaebler.com

Series C - Aviceda Therapeutics - 2025-01-07 - Crunchbase

3 weeks from now

Jan 8, 2025  · Aviceda Therapeutics raised $207500000 on 2025-01-07 in Series C. Start Free Trial . Chrome Extension

crunchbase.com

Aviceda Therapeutics Raises Upsized $207.5 Million In Series C ...

3 weeks from now

Jan 7, 2025  · Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round to Advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials

times-online.com

Founder Lodge | 225+ Founders $3.2B Raised’s Post - LinkedIn

3 weeks from now

Founder Lodge | 225+ Founders $3.2B Raised’s Post ... Aviceda Therapeutics raised $207,500,000 in Series C-Congrats Michael Tolentino Full Round Info: https: ... PetTech/Pet …

linkedin.com

Aviceda Therapeutics Raises Upsized $207.5 Million In Series C ...

3 weeks from now

Chen Yu, M.D., M.B.A., Founder and Managing Partner at TCGX, added, “Aviceda’s focus on data quality and execution is evident in the progress of the AVD-104 program, and we believe …

vcaonline.com

See Which Top Bergen County Officials Got Raises Of 10% And Higher

3 weeks from now

Mar 1, 2023  · Commissioners in neighboring Passaic County were paid $35,000, in Essex County $42,019 and in Hudson County $47,305 per year in 2021. The county executive and …

northjersey.com